Free Trial
OTCMKTS:OSSFF

Embla Medical hf. (OSSFF) Stock Price, News & Analysis

Embla Medical hf. logo
$4.15 0.00 (0.00%)
As of 07/3/2025

About Embla Medical hf. Stock (OTCMKTS:OSSFF)

Key Stats

Today's Range
$4.15
$4.15
50-Day Range
$4.15
$4.15
52-Week Range
$4.08
$5.18
Volume
N/A
Average Volume
560 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OSSFF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Embla Medical hf. and its competitors with MarketBeat's FREE daily newsletter.

OSSFF Stock News Headlines

Jon Ossoff
See More Headlines

OSSFF Stock Analysis - Frequently Asked Questions

Embla Medical hf.'s stock was trading at $4.77 at the start of the year. Since then, OSSFF stock has decreased by 13.0% and is now trading at $4.15.

Shares of OSSFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/05/2025
Next Earnings (Estimated)
7/22/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
OTCMKTS:OSSFF
Fax
N/A
Employees
3,999
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:OSSFF) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners